Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation-Reference-Cited by-同舟云学术

Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation

Published:1991-04 Issue:2 Volume:124 Page:204-207
ISSN:0304-3940
Container-title:Neuroscience Letters
language:en
Short-container-title:Neuroscience Letters

Author:

Benoliel J.J.,Bourgoin S.,Mauborgne A.,Legrand J.C.,Hamon M.,Cesselin F.

Publisher

Elsevier BV

Subject

General Neuroscience

Reference20 articles.

1. The role of CCK, caerulein, and CCK antagonists in nociception;Baber;Pain,1989

2. Modulations of the in vitro release of CCK8-like material from the rat substantia nigra by μ, δ, and κ opioid receptor agonists;Benoliel,1989

3. Antagonism of μ-opioid receptor-mediated inhibitions of nociceptive neurones by U 50488 H and dynorphin A1–13 in the rat dorsal horn;Dickenson;Neurosci. Lett.,1987

4. Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364.718;Dourish;Eur. J. Pharmacol.,1988

5. The selective CCK-B receptor antagonist L-365.260 enhances morphine analgesia and prevents morphine tolerance in the rat;Dourish;Eur. J. Pharmacol.,1990

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why mu-opioid agonists have less analgesic efficacy in neuropathic pain?;European Journal of Pain;2018-11-25

2. The impact of opioid-induced hyperalgesia for postoperative pain;Best Practice & Research Clinical Anaesthesiology;2007-03

3. Opioid-induced hyperalgesia—Pathophysiology and clinical relevance;Acute Pain;2007-03

4. Cholecystokinin Peptides in Brain Function;Handbook of Neurochemistry and Molecular Neurobiology;2006

5. Cholecystokinin and endogenous opioid peptides: Interactive influence on pain, cognition, and emotion;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2005-12